Expansion of Mucin-Reactive T-helper Lymphocytes from Patients with Colorectal Cancer
- 1 January 1995
- journal article
- research article
- Published by Mary Ann Liebert Inc in Cancer Biotherapy
- Vol. 10 (2) , 115-123
- https://doi.org/10.1089/cbr.1995.10.115
Abstract
The ability to identify and expand effector cells with reactivity against tumor-associated antigens (TAA) is critical for effective adoptive cellular therapy. The purpose of this study was to assess lymph node lymphocytes sensitized in vivo to the shed TAA TAG-72 as a potential source of cells for adoptive cellular therapy. Lymph nodes containing microscopic tumor and/or shed TAG-72+ mucin were localized using radiolabeled CC49 monoclonal antibody and a gamma detector at the time of exploratory colorectal surgery. Lymph nodes containing microscopic tumor and shed mucin exhibited approximately 40-fold expansion in short-term (+ mucin. In addition,CD4+ cells expressed mRNA for IL-2, IL-4, tumor necrosis factor-β and IFNg, and retained the ability to secrete IL-2 after expansion. Thus, noncytolytic, cytokine-secreting, mucin-reactive T- cells can be expanded from lymph nodes of patients with colorectal cancer. These cells provide the basis for T-helper adoptive cellular therapy programs of patients with advanced colorectal cancer.Keywords
This publication has 4 references indexed in Scilit:
- Localization of tumor-reactive lymph node lymphocytes in vivo using radiolabeled monoclonal antibodyCancer, 1994
- A Phase II Clinical Trial of Interleukin-2 and Lymphokine-Activated Killer Cells in Advanced Colorectal CarcinomaJournal of Immunotherapy, 1994
- DETECTION OF CYTOKINE mRNA IN VIVO BY POLYMERASE CHAIN REACTIONTransplantation, 1993
- Prospective randomised trial of early cytotoxic therapy for recurrent colorectal carcinoma detected by serum CEA.Gut, 1984